Globeflex Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.47M Buy
84,145
+28,784
+52% +$2.25M 0.98% 26
2025
Q4
$4.37M Buy
55,361
+24,757
+81% +$2.14M 0.67% 49
2025
Q3
$2.8M Buy
30,604
+20,007
+189% +$1.63M 0.43% 70
2025
Q2
$691K Hold
10,597
0.06% 229
2025
Q1
$709K Hold
10,597
0.07% 217
2024
Q4
$586K Hold
10,597
0.05% 253
2024
Q3
$632K Hold
10,597
0.06% 238
2024
Q2
$675K Sell
10,597
-1,052
-9% -$68.3K 0.07% 220
2024
Q1
$805K Sell
11,649
-1,257
-10% -$75.9K 0.08% 212
2023
Q4
$712K Hold
12,906
0.07% 232
2023
Q3
$749K Buy
12,906
+6,306
+96% +$364K 0.09% 207
2023
Q2
$355K Buy
+6,600
New +$293K 0.04% 283
2022
Q2
Sell
-21,919
Closed -$616K 482
2022
Q1
$616K Hold
21,919
0.12% 206
2021
Q4
$1.01M Hold
21,919
0.21% 157
2021
Q3
$719K Hold
21,919
0.16% 200
2021
Q2
$768K Hold
21,919
0.14% 231
2021
Q1
$792K Hold
21,919
0.14% 229
2020
Q4
$637K Sell
21,919
-19,293
-47% -$553K 0.14% 246
2020
Q3
$1.16M Buy
41,212
+1,755
+4% +$52.3K 0.31% 93
2020
Q2
$1.28M Buy
39,457
+1,302
+3% +$46.7K 0.32% 82
2020
Q1
$1.55M Sell
38,155
-811
-2% -$43.1K 0.48% 39
2019
Q4
$2.4M Buy
38,966
+9,126
+31% +$605K 0.45% 38
2019
Q3
$2.17M Buy
29,840
+2,138
+8% +$160K 0.48% 39
2019
Q2
$2.28M Hold
27,702
0.47% 39
2019
Q1
$1.95M Buy
27,702
+17,802
+180% +$1.05M 0.41% 51
2018
Q4
$446K Hold
9,900
0.11% 293
2018
Q3
$560K Sell
9,900
-2,400
-20% -$147K 0.11% 280
2018
Q2
$822K Buy
12,300
+1,200
+11% +$74.9K 0.17% 209
2018
Q1
$646K Sell
11,100
-17,515
-61% -$1.11M 0.14% 247
2017
Q4
$1.84M Buy
28,615
+1,700
+6% +$106K 0.51% 39
2017
Q3
$1.41M Buy
+26,915
New +$1.28M 0.4% 70

Other funds holding ANIP